Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

November 30, 2010

Conditions
RhinoconjunctivitisAllergies
Interventions
DRUG

CYT003-QbG10

subcutaneous injection

DRUG

Placebo

subcutaneous injection

Trial Locations (8)

Unknown

Cytos Investigator Sites, Paide, Tartu, Tallin, Rakvere

Cytos Investigator Sites, Fulda, Dresden, Ulm, Rodgau, Kassel, Eisenach

Cytos Investigator Sites, Wiesbaden, Frankfurt/M, Leipzig, Jena, Hamburg, Dulmen

Cytos Investigator Sites, N. Faliro, Hiraklion, Athens

Cytos Investigator Sites, Riga, Rezekne

Cytos Investigator Sites, Vilnius, Kaunas, Klaipeda

Cytos Investigator Sites, Galati, Cluj Napoca, Bahia Mare, Brasov, Piesti

Cytos Investigator Sites, Targu Mures, Bukarest, Craiova, Iasi

Sponsors
All Listed Sponsors
lead

Cytos Biotechnology AG

INDUSTRY